-
Sep 12, 12 Clinical Updates
Swiss drugmaker Novartis told India’s top court it had demonstrated the improved efficacy of its cancer drug Glivec as the… »
Sep 07, 12 Clinical UpdatesA small trial of Peregrine Pharmaceuticals Inc’s experimental drug, bavituximab, showed that it doubled the length of time lung cancer… »
Sep 05, 12 FDA ApprovalsThe U.S. Food and Drug Administration today approved Bosulif (bosutinib) to treat chronic myelogenous leukemia (CML), a blood and bone… »
Sep 03, 12 Clinical UpdatesGerman healthcare conglomerate Fresenius has dropped its attempt to take over Rhoen-Klinikum after two other companies bought stakes to block… »
Sep 03, 12 FDA ApprovalsA new drug designed to treat advanced prostate cancer that isn’t responding to other therapies received U.S. Food and… »
Aug 31, 12 FDA ApprovalsA prostate cancer drug developed by Medivation Inc and Astellas Pharma Inc has been approved by the U.S. Food and… »
Aug 31, 12 Drug NewsU.S. drug reviewers questioned whether Novartis AG’s experimental inhaled antibiotic powder truly helped cystic fibrosis patients breathe better, according to… »
Aug 29, 12 Clinical UpdatesJohnson & Johnson said an application to gain approval for a new usage of its prostate cancer treatment Zytiga won… »
Aug 29, 12 Clinical UpdatesMUNICH: The expiry of patents on profitable heart medicines is soon going to erode one of the main sources of… »
Aug 29, 12 FDA ApprovalsAbbott Laboratories Inc. won a U.S. panel’s support Tuesday for wider use of its blockbuster Humira drug in a type… »
Subscribe to the "News" RSS Feed
TOP ۞